Iperionx LTD

Form 420-F13G

Insider Trading (Form 4)

See all →
NASDAQ
Beverly Wyse, a Director of IPERIONX Ltd, reported multiple transactions in common stock on July 15, 2026.
NASDAQ
R Tony Tripeny, a Director of IPERIONX Ltd, purchased 3,846 shares of common stock on July 14, 2026 for $26.00 per share.
NASDAQ
Lorraine M Martin, a Director of IPERIONX Ltd, purchased 4,100 shares of common stock on July 10, 2026 for $24.51 per share.
NASDAQ
Toby Edgcumbe Symonds, President of IPERIONX Ltd, purchased 2,040 shares of common stock on July 10, 2026 for $24.55 per share.
NASDAQ
Anastasios Arima, Chief Executive Officer and a Director of IPERIONX Ltd, purchased 138,720 shares of common stock on July 10, 2026 for $3.58 per share.
NASDAQ
Todd Hannigan, Executive Chairman and a Director of IPERIONX Ltd, purchased 525,000 shares of common stock on July 10, 2026.

Schedule 13G - Passive Investments

NASDAQ
Regal Funds Management Pty Limited has reported a 2.63% beneficial ownership stake in Iperionx Ltd, holding 8,811,766 shares.
NASDAQ
Regal Funds Management Pty Limited and Regal Partners Limited have disclosed a 5.92% beneficial ownership stake in Iperionx Limited, totaling 18,953,963 ordinary shares.
NASDAQ
Regal Funds Management Pty Limited and Regal Partners Limited have disclosed a significant 7.29% beneficial ownership stake in Iperionx Limited, comprising over 23 million shares.
NASDAQ
FMR LLC and Abigail P. Johnson have reported a continued beneficial ownership of 8.2% of IPERIONX LTD's common stock as of December 31, 2024, through an amended Schedule 13G filing.
NASDAQ
FIL Limited, along with its affiliates Pandanus Partners, L.P. and Pandanus Associates, Inc., has disclosed a beneficial ownership of 3.1% in IperionX Ltd's common stock as of December 31, 2024.